Michael Meyers on Muck Rack

Michael Meyers

Illinois
As seen in: Royals Blue, HuffPost, Nature, New York Daily News, The Wall Street Journal, Chicago Tribune, Chicago Tribune Opinion, Taylor & Francis Online, JAMA (The Journal of the American Medical Association), National Review, The Daily Caller and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Michael

Contact Michael, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Reed Smith represents EquiLend in acquisition of Finadium

|
By Christopher M. Sheaffer, Anatoliy Rozental, Lowell P. Bourgeois, Michael Meyers, Adam Fink, Kiran V. Somashekara, Ian Sherwin, Zachary Baker, Peter A. Emmi, Paulo McKeeby, Joseph J. Mammone, Tyler Thompson, Erin Stidham, Talia Boiangin Behar, Simon M. Kliegman
| reedsmith.com
NEW YORK – Global law firm Reed Smith represented EquiLend, a Welsh Carson portfolio company, in connection with its acquisition of Finadium, a research and consultancy firm serving the securities finance, repo, collateral, prime brokerage, and capital markets infrastructure industries. Finadium will operate as a subsidiary of EquiLend while maintaining its operational independence.
Open in Who Shared View Duplicates (2) Issue with article?

A small-molecule inverse agonist of PPARγ for advanced solid tumors: a phase 1 trial - Nature Medicine

|
By Matthew D. Galsky, Charlene M. Mantia, Michaela Bowden, Joaquim Bellmunt, Benjamin Garmezy, Gopa Iyer, Daniel P. Petrylak, Drew Rasco, Shilpa Gupta, Phuong Nguyen Verified, Phương Nguyên, Jennifer Tepper, Alex Rossi Verified, Jennifer A Mertz, Evisa Gjini, Michael Meyers, Matthew I. Milowsky, Xin Gao, Ildefonso Rodriguez-Rivera, Yelena Mikhailov, Adarsh Joshi, Bijal Kakrecha, Anne Marie Costa, Carolyn McCrone
| Nature Verified
Abstract Peroxisome proliferator-activated receptor gamma (PPARγ) is a master regulator of luminal lineage in urothelial carcinoma. FX-909 is a first-in-class oral small-molecule PPARγ inverse agonist. Here we report the first part of FX-909-CLINPRO-1, a phase 1A 3 + 3 dose-escalation study of FX-909, that enrolled 56 patients with advanced solid tumors, including 46 with urothelial carcinoma.
Open in Who Shared Issue with article?

10 games Warner Bros. should make now -

|
By Michael Meyers
| Royals Blue
This may be a bit of a pointless article to write, since Warner Bros. has actively admitted it is for sale. But I guess whoever ends up buying the rights to its IPs or the studio itself could also use this as a brainstorming activity for what games the studio could and should make. Without further ado, let’s get down to business. I know Suicide Squad: Kill the Justice League didn’t work out, but the idea of a co-op Arkham-like game wasn’t necessarily bad in my opinion.
Open in Who Shared Issue with article?
See all 1,116 licensed articles (1,123 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified